BioBot - a public health research, data and analytics firm co-founded by Mariana Matus PhD '18 and Newsha Ghaeli PhD '17 - is using wastewater testing to provide insights into growing infection rates and diseases across the country, reports Soledad O’Brien for WCVB-TV.
Research scientist Beth Pollack speaks with the New York Times’ Pam Belluck about her work studying the mechanisms of long Covid-19 and myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). “Experts said the study, which is the N.I.H’s first detailed look at ME/CFS, should be considered only one step in understanding the condition, its severity and potential remedies,” explains Belluck. “We must advance the field towards research on treatment,” says Pollack.
Researchers at MIT and elsewhere have found that while AI systems could help doctors come to the right diagnosis more often, the diagnostic gains aren’t always distributed evenly, with more improvements tied to patients with lighter skin, report Daniel Payne, Erin Schumaker, and Ruth Reader for Politico. “AI could be a powerful tool to improve care and potentially offer providers a check on their blindspots," they write. "But that doesn’t mean AI will reduce bias. In fact, the study suggests, AI could cause greater disparities in care.”
Alicia Chong Rodriguez SM ’17, SM ’18 founded Bloomer Tech, a health tech startup that aims to improve health care diagnostics for women using medical-grade data to develop new therapies and care models, reports Carol Eisenberg for The Washington Post. Rodriguez and her colleagues "developed, patented and tested flexible washable circuits to turn articles of clothing into devices that can relay reams of information to the wearer’s smartphone,” writes Eisenberg.
Prof. Canan Dagdeviren and her team have developed a wearable ultrasound patch that can be used to screen for breast cancer at home, reports Grace Browne for Wired. “Dagdeviren wants to give people the opportunity to know what’s happening inside their bodies every day, the same way we check the weather forecast,” writes Browne.
A new analysis from MIT researchers has found that preventative screenings such as a colonoscopy and sigmoidoscopy can reduce cancer rates more than previous analyses suggested, reports Ernie Mundell for HealthDay. “Prior colon cancer screening studies found that regular colonoscopy/sigmoidoscopy reduced that rate by 25% -- to 0.75%,” explains Mundell. “But the new analysis took into account the number of participants in a colon cancer screening trial who decided, for whatever reason, to skip screening. When these "non-adherent" folks were eliminated from statistical calculations, the actual percentage of people who went on to develop colon cancer over a 10-year span fell to just 0.5%.”
Writing for Fast Company, Lecturer Guadalupe Hayes-Mota '08, SM '16, MBA '16 shares three strategies that are reshaping access to healthcare and medicine, especially in low-and middle-income countries (LMICs). “Integrating local production enhancement, strategic partnership and pooled purchasing power represents a new dawn in global health care,” writes Hayes-Mota. “These innovative approaches are pivotal in making quality medicine and healthcare accessible to all, particularly LMICs.”
Forbes contributor William Haseltine spotlights how MIT researchers developed a biosensor ingestible capsule that can gather and transmit information on a patient’s condition to a physician. Haseltine notes that “aside from respiratory and heart rate monitoring, future applications for the pill could come from alterations in its design, leading to other avenues of health monitoring. These may include digestive health, blood sugar monitoring and cancer cell detection.”
Lecturer Guadalupe Hayes-Mota '08, SM '16, MBA '16 writes for the National Academy of Engineering to discuss the importance of a “well-functioning healthcare supply chain.” “A connected supply chain represents a paradigm shift, offering the potential to revolutionize how drugs are developed, produced, and delivered to patients,” writes Hayes-Mota. “Embracing this approach can enhance drug delivery efficiency, ensure patient satisfaction, and ultimately contribute to a healthier and more prosperous global community.”
Forbes contributor William Haseltine spotlights how MIT researchers have developed a flexible ultrasound patch that can be used to help estimate bladder volume. “The applications for long-term therapeutic and regenerative medicine for the ultrasound patch are innumerable, only to be limited by the imagination of those implementing their use,” writes Haseltine. “Among the most forthcoming are situations where someone may be unable to visit their physician for a medically-administered ultrasound.”
Researchers from MIT and elsewhere are developing an electronic pill that can “measure heart rate, breathing rate and core temperature – from inside a human stomach,” reports Celia Ford for Wired. “We have a solution that’s relatively simple and enables access broadly,” says Prof. Giovanni. “I think that can be really transformative.”
Researchers from MIT and elsewhere have developed a swallowable “technopill” that can monitor vital signs from inside the body, reports Dennis Thompson for HealthDay. “The ability to facilitate diagnosis and monitor many conditions without having to go into a hospital can provide patients with easier access to healthcare and support treatment,” says Prof. Giovanni Traverso.
A team including researchers from MIT have developed a new ingestible ‘smart capsule’ that uses a patient’s vital signs to detect sleep disorders or opioid overdoses. “The findings suggest that the ingestible was able to measure health metrics on par with medical-grade diagnostic equipment at the sleep center,” writes Malak Saleh for Engadget.
Prof. Gio Traverso speaks with Lizzy Lawler at STAT about a new ingestible sensor that monitors a person’s heart and breathing rates to detect sleep disorders. “The vision for sleep evaluation is the ability to detect these events wherever you are in the nation, and not having to go to a sleep lab and an inpatient setting,” says Traverso.
New Scientist reporter Alice Klein writes that MIT researchers have developed an ingestible electronic device that “can measure your breathing and heart rate from inside your gut [and] could potentially diagnose sleep apnea and even detect opioid overdoses.” The device could one day allow “people to be assessed for sleep apnea wirelessly and cheaply while at home.”